/* Product view custom css */
Anglo-French Drugs & Industries Ltd

Anglo-French Drugs & Industries Ltd

Master

Anglo-French Drugs & Industries Ltd

Face Value 10
ISIN No INE570E01016

You Can Buy The Below Quantity From Us By Clicking On “Buy Now” Or For More & Bulk Quantity, You Can Contact Us On: 02249369990 / 09867572101 / 09987204585
ID Face Value Quantity Rate Amount Mode Minimum Lot Size  
1011247 10 40 Rs 1560.00 Rs 62,400.00 Rs Unlisted Demat 10
1009785 10 60 Rs 1570.00 Rs 94,200.00 Rs Unlisted Demat 10

Company Information


Anglo- French Drugs & Industries Limited Unlisted Shares


Board of Directors

Chairman

: Mr. Abhay Kanoria

Managing Director

: Mr. Uddhav Abhay Kanoria and Mr. Nirbhay Abhay Kanoria

Company Secretary

: Mrs. Sriee Aneetha. M

Chief Financial Officer

: Mr. Manik Kumar Singh

Independent Director

: Mrs.Rani Shokeen, Mr. Srinivasan Krishnan, Mr. Pradeep Vasantarao Joshi


Background

The company is primarily engaged in manufacturing of pharmaceutical formulations, trading, exports and treasury business.


Registered Office

No.101, 1st Floor, Orbit Plaza, New Prabhadevi Road, Prabhadevi, Mumbai – 400 025


INCORPORATION YEAR

: 1923

WEBSITE

: www.afdil.com

EMAIL

: compliance@afdil.com

CIN NO

: L24230MH1923PLC463682

ISIN NO.

: INE570E01016

FACE VALUE

: Pharmaceuticals & Drugs

FACE VALUE

: 10

PROMOTER HOLDING

: 65%


Financial Information for Last 3 Years (Rupees In Crore)

Particulars

2026

2025

2024

Equity Capital

1.13

1.13

1.23

Reserve & Surplus

146.36

123.67

169.67

Net worth

147.49

124.80

170.90

Book Value Per share Rs.

1305.22

1104.42

1389.43

Total Income

129.39

117.99

99.84

Profit/(Loss)

22.81

7.22

(12.34)

EPS Rs.

202

62

(99)


Annual Report of Anglo- French Drugs & Industries Limited Unlisted Shares


Annual Report of Anglo- French Drugs & Industries Limited– 2026

Annual Report of Anglo- French Drugs & Industries Limited– 2025

Annual Report of Anglo- French Drugs & Industries Limited– 2024

Cookie Consent

We use cookies to ensure you have the best browsing experience on our website. By using our site, you acknowledge that you have read and understood our Cookie Policy & Privacy